ARTICLE | Company News
Galapagos, Vertex in proteomics deal
August 22, 2001 7:00 AM UTC
Galapagos Genomics (Mechelen, Belgium) will use its PhenoSelect platform to provide VRTX with custom recombinant adenoviruses. VRTX will use the adenoviruses to characterize the protein activity of ce...